These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36397618)

  • 1. Inflammation as Treatment Target for Status Epilepticus.
    Rejdak K; Pikulicka A; Piekarska M; Pacek K; Płachta K
    Curr Neuropharmacol; 2023; 21(3):708-714. PubMed ID: 36397618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Torres AR
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.
    Kravljanac R; Djuric M; Jankovic B; Pekmezovic T
    Eur J Paediatr Neurol; 2015 Sep; 19(5):584-90. PubMed ID: 26143956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.
    Vezzani A; Dingledine R; Rossetti AO
    Expert Rev Neurother; 2015; 15(9):1081-92. PubMed ID: 26312647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-onset refractory status epilepticus in an adult with an atypical presentation of cat-scratch disease: successful treatment with high-dose corticosteroids.
    Laswell EM; Chambers KD; Whitsel DR; Poudel K
    Pharmacotherapy; 2015 Jun; 35(6):e106-10. PubMed ID: 26044784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
    Khawaja AM; DeWolfe JL; Miller DW; Szaflarski JP
    Epilepsy Behav; 2015 Jun; 47():17-23. PubMed ID: 26010959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status epilepticus].
    Buompadre MC
    Medicina (B Aires); 2018; 78 Suppl 2():12-17. PubMed ID: 30199359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
    Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
    Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
    Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
    Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and course of different subtypes of status epilepticus.
    Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
    Epilepsy Res; 2013 Nov; 107(1-2):156-62. PubMed ID: 24016689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of new-onset refractory status epilepticus (NORSE) in adults.
    Suchdev K; Kupsky WJ; Mittal S; Shah AK
    Seizure; 2021 Dec; 93():95-101. PubMed ID: 34740145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New onset refractory status epilepticus (NORSE).
    Sculier C; Gaspard N
    Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.
    Gall CR; Jumma O; Mohanraj R
    Seizure; 2013 Apr; 22(3):217-20. PubMed ID: 23333762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset refractory status epilepticus (NORSE) in paediatric patients: causes, characteristics and outcomes.
    Tainski de Azevedo AL; Tedesco Tonial C; Andrades GRH; Abud Drumond Costa C; Crestani F; Rodrigues Lessa A; Bruno F; Carvalho P; Eckert G; Piva J; Celiny Ramos Garcia P
    BMJ Neurol Open; 2022; 4(2):e000314. PubMed ID: 36530417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-Onset Status Epilepticus in Pediatric Patients: Causes, Characteristics, and Outcomes.
    Jafarpour S; Hodgeman RM; De Marchi Capeletto C; de Lima MTA; Kapur K; Tasker RC; Loddenkemper T
    Pediatr Neurol; 2018 Mar; 80():61-69. PubMed ID: 29373157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.